通化金马 (000766)
TONGHUA GOLDEN-HORSE PHARMACEUTICAL INDUSTRY CO,LTD
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 96649.47
- Circulating A-Shares(W): 96600.77
- Earnings Per Share(RMB): 0.0258
- Net Assets Per Share(RMB): 2.3810
- Operating Revenue(W RMB): 89225.11
- Total Profit(W RMB): 3458.83
- Net Profit Attributable to Parent(W RMB): 2496.35
- Net Profit Growth Rate(%): 4.35
- Weighted Return on Equity(%): 1.1000
- Operating Cash Flow Per Share(RMB): 0.0730
- Undistributed Profit Per Share(RMB): -2.3336
- Capital Reserve Per Share(RMB): 3.7034
2. Main Business
The main business covers:
- R&D, production and sales of pharmaceutical products
3. Company Basic Information
- Company Name: Tonghua Golden-horse Pharmaceutical Industry Co., Ltd.
- Listing Date: 1997-04-30
- Industry: Pharmaceutical Manufacturing
- Address: No. 999 Jinma Road, Erdaojiang District, Tonghua City, Jilin Province
- Website: www.thjm.cn
- Company Profile：The company was jointly established in 1993 by three enterprises including Tonghua Biochemical Pharmaceutical Factory. Initially, the net assets of the promoters were converted into 31.196 million state shares and 36.929 million legal person shares. 20.575 million private placement legal person shares and 55.1 million employee shares were issued. After a 1:0.6 share consolidation on December 21, 1996, and the first online pricing issuance on April 18, 1997, the total number of shares at the time of listing was 126.28 million.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Shanghai Mukai Trading Co., Ltd. | General Legal Person | 4699.20 | 4.86 |
| 2 | Tonghua Yongxin Investment Co., Ltd. | General Legal Person | 2000.00 | 2.07 |
| 3 | Yinhua CSI Innovative Pharmaceutical Industry ETF | Fund | 919.30 | 0.95 |
| 4 | Southern CSI 1000 ETF | Fund | 884.16 | 0.92 |
| 5 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 726.71 | 0.75 |
| 6 | ChinaAMC CSI 1000 ETF | Fund | 525.31 | 0.54 |
| 7 | Huafu CSI 300 Index Enhanced Securities Investment Fund Class A | Fund | 3.30 | 0.00 |
| 8 | <值> | <值> | <值> | <值> |
| 9 | <值> | <值> | <值> | <值> |
| 10 | <值> | <值> | <值> | <值> |
5. Concept Sectors
- Private Hospital
- Industrial Hemp
- Hepatitis Concept
- Innovative Drug
- DeepSeek
- Margin Trading & Securities Lending
- High P/E Ratio
- Long-term No Dividend
- Non-Cyclical Stock
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information